Intention to Treat: When Race Matters (Promo)

Why It Matters

The bias can cause under‑treatment of minority patients, worsening health disparities and exposing hospitals to legal and reputational risk.

Key Takeaways

• Pulse oximeters misread oxygen levels in darker-skinned patients.
• Studies show systematic overestimation for Black and Brown individuals.
• Errors persisted despite evidence, influencing COVID-19 triage decisions.
• Clinicians often unaware of device bias affecting patient care.
• Calls for redesign and regulatory oversight of oximeter technology.

Summary

The video highlights that pulse oximeters, once hailed as a breakthrough, systematically mismeasure oxygen saturation in patients with darker skin tones.

Research cited shows the devices overestimate SpO2 by up to 3‑4 percentage points for Black and Brown patients, a bias that was exposed during the COVID‑19 pandemic when oximeter readings guided home‑care versus hospital admission decisions.

The narrator points out that despite peer‑reviewed studies and FDA warnings, many clinicians remain unaware of the flaw, leading to delayed treatment and higher mortality among minority groups.

The episode calls for manufacturers to redesign sensors, for regulators to enforce bias testing, and for clinicians to adopt supplemental assessment methods, underscoring a broader need for equity in medical device validation.

Original Description

Are pulse oximeters serving everyone equally in health care? Rachel Gotbaum, host and producer of “Intention to Treat,” explores the overlooked bias in pulse oximetry in episode 4.

Listen wherever you get your podcasts.

#clinicalmedicine #medicalpractice #nejm